Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment. 2014

Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
Genostar, 60 rue Lavoisier, Montbonnot 38330, France. miganeh@genostar.com.

Pseudomonas aeruginosa is a Gram-negative environmental species and an opportunistic microorganism, establishing itself in vulnerable patients, such as those with cystic fibrosis (CF) or those hospitalized in intensive care units (ICU). It has become a major cause of nosocomial infections worldwide and a serious threat to Public Health because of overuse and misuse of antibiotics that have selected highly resistant strains against which very few therapeutic options exist. Herein is illustrated the intraclonal evolution of the genome of sequential isolates collected in a single CF patient from the early phase of pulmonary colonization to the fatal outcome. We also examined at the whole genome scale a pair of genotypically-related strains made of a drug susceptible, environmental isolate recovered from an ICU sink and of its multidrug resistant counterpart found to infect an ICU patient. Multiple genetic changes accumulated in the CF isolates over the disease time course including SNPs, deletion events and reduction of whole genome size. The strain isolated from the ICU patient displayed an increase in the genome size of 4.8% with major genetic rearrangements as compared to the initial environmental strain. The annotated genomes are given in free access in an interactive web application WallGene  designed to facilitate large-scale comparative analysis and thus allowing investigators to explore homologies and syntenies between P. aeruginosa strains, here PAO1 and the five clinical strains described.

UI MeSH Term Description Entries

Related Publications

Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
December 2004, Journal of clinical microbiology,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
February 2008, Proceedings of the National Academy of Sciences of the United States of America,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
October 1986, Gigiena i sanitariia,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
April 1966, The Journal of infectious diseases,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
January 2019, Frontiers in microbiology,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
January 1971, Rinsho byori. The Japanese journal of clinical pathology,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
January 1971, Rinsho byori. The Japanese journal of clinical pathology,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
December 1969, Canadian journal of medical technology,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
January 1980, Mikrobiyoloji bulteni,
Céline Lucchetti-Miganeh, and David Redelberger, and Gaël Chambonnier, and François Rechenmann, and Sylvie Elsen, and Christophe Bordi, and Katy Jeannot, and Ina Attrée, and Patrick Plésiat, and Sophie de Bentzmann
March 1976, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!